1Bowne WB,Antonescu CR,Leung DH,et al.Dermatofibrosarcoma protuberans:a clinicopathologic analysis of patients treated and followed at a single institution.Cancer,2000,88:2711-2720.
3Iwasaki H,Ohjimi Y,Ishiguro M,et al.Supernumerary ring chromosomes and nuclear blebs in some low-grade malignant soft tissue tumours:atypical lipomatous tumours and dermatofibrosarcoma protuberans.Virchows Arch,1998,432:521-528.
4Bridge JA,Neff JR,Sandberg AA.Cytogenetic analysis of dermatofibrosarcoma protuberans.Cancer Genet Cytogenet,1990,49:199-202.
5Mandahl N,Heim S,Willen H,et al.Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans.Cancer Genet Cytogenet,1990,49:273-275.
6Pedeutour F,Simon MP,Minoletti F,et al.Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosomes 17 and 22 sequences.Cancer Res,1995,55:2400-2403.
7Minoletti F,Miozzo M,Pedeutour F,et al.Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans.Genes Chromosomes Cancer,1995,13:62-65.
8Nishio J,Iwasaki H,Ishiguro M,et al.Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22:a fluorescence in situ hybridization and comparative genomic hybridization analysis.Genes Chromosomes Cancer,2001,30:305-309.
9Dobin SM,Diaz JA,Silva MT,et al.Translocation (17;22)(q22;q13) in a case of subcutaneous dermatofibrosarcoma protuberans in an adult.Cancer Genet Cytogenet,1999,109:86-87.
10O'Brien KP,Seroussi E,Dal Cin P,et al.Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.Genes Chromosomes Cancer,1998,23:187-193.
二级参考文献12
1Enzinger FM, Weiss SW.Fibrohistiocytic tumors. In:Enzinger FM ,Weiss SW,eds. Soft Tissue Tumors. St. Louis:Mosby, 1995. 325-349.
2Mrozek K,Iliszko J,Rys J ,et al.Spectral karyotyping reveals 17;22 fusion in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality. Genes Chromosomes Cancer,2001,31:182-186.
3Pedeutour F, Simon MP, Minoletti F, et al.Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement.Cytogenet Cell Genet, 1996,72:171-174.
4Wang J, Hisaoka M, Shimajiri S, et al.Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.Diagn Mol Pathol, 1999,8:113-119.
5Greco A, Fusetti L, Villa R, et al.Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans.Oncogene,1998, 17:1313-1319.
6Maire G, Martin L, Michalak-Provost S, et al.Fusion of COL1A1 exon 29 with PDGFB exon 2 in a der(22)t(17;22) in a pediatric giant cell fibroblastoma with a pigmented Bednar tumor component. Evidence for age-related chromosomal pattern in dermatofibrosarcoma protuberans and related tumors. Cancer Genet Cytogenet, 2002, 134:156-161.
7O′Brien KP, Seroussi E, Dal Cin P, et al.Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.Genes Chromosomes Cancer, 1998,23:187-193.
8Shimizu A, O′Brien KP, Sjoblom T, et al.The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.Cancer Res, 1999,59:3719-3723.
9Simon MP, Navarro M, Roux D,et al.Structural and functional analysis of a chimerical protein COL1A1/PDGFB generated by the translocation t(17;22)(q22;q13.1) in dermatofibrosarcoma protuberans .Oncogene,2001,20:2965-2975.
10Simon MP, Pedeutour F, Sirvent N, et al.Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.Nat Genet,1997 15:95-98.
3Gloster HM, Harris KR, Roenigk RK. A comparison between Mobs micrographic surgery and wide surgical excision for treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996 ; 35 ( 1 ) : 82 - 87.
4Filipowicz EA, Ventura KC, Pou AM, et al. FNAC in the diagnosis of recurrent dermatofibrosarcoma protuberans of the forehead: A case report. Acta Cytol 1999;43(6) : 1177 - 1180.
5Ballo MT, Zagars GK, Pisters P, et al. The role of radiation thempy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys 1998;40(4):823- 827.
6Bowne WB, Antonescu CR, Leung DH, et al. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer 2000; 88 (12) : 2711 - 2720.
8Bowne WB,Antonescu CR,Leung DH,et al.Dermatofibrosarcoma protuberans:a clinicopathologic analysis of patients treated and followed at a single institution[J].Cancer,2000,88(12):2711-2720.
9Chang CK,Jacobs IA,Salti GI.Outcomes of surgery for dermatofibrosarcoma protuberans[J].EurJ Surg Oncol,2004,30(3):341-345.
10Fiore M,Miceli R,Mussi C,et al.Dermatofibrosarcoma protuberans treated at a single institution:a surgical disease with a high cure rate[J].J Clin Oncol,2005,23(30):7669-7675.
